7 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 5.6% per year over the past 5 years.
Net income has grown faster than revenue (26.7% vs 5.6% per year).
Operating margin has expanded, at 9.5% in the latest year.
Free cash flow has grown 26.9% per year over the past 5 years.
Financial health
The company holds more cash ($647M) than total debt ($353M).
Total debt has grown slower than revenue (-3.6% vs 5.6% per year).
Total debt is 0.8× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$3.6B
$278M
23.8%
9.5%
$227M
$353M
$647M
2024
$3.2B
$213M
22.8%
9.1%
$186M
$370M
$598M
2023
$2.8B
$168M
22.9%
8.2%
$145M
$442M
$467M
2022
$2.7B
$405M
21.4%
20.8%
-$32M
$406M
$306M
2021
$2.9B
$154M
19.0%
8.2%
$118M
$408M
$240M
2020
$2.8B
$85M
17.8%
6.5%
$69M
—
$61M
2019
$2.7B
$75M
16.9%
6.0%
$102M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$846M
$62M
25.1%
9.1%
-$96M
—
$328M
Dec '25
$1.1B
$102M
25.4%
11.9%
$376M
$353M
$647M
Sep '25
$960M
$72M
23.1%
9.7%
$77M
—
$309M
Jun '25
$829M
$54M
23.8%
8.4%
-$56M
—
$278M
Mar '25
$799M
$50M
22.7%
7.4%
-$170M
—
$380M
Dec '24
$981M
$89M
24.0%
12.2%
$414M
$370M
$598M
Sep '24
$812M
$57M
22.0%
9.2%
$47M
—
$198M
Jun '24
$753M
$38M
22.4%
7.3%
$0
—
$149M
Mar '24
$688M
$29M
22.2%
6.3%
-$275M
—
$160M
Dec '23
$926M
$74M
22.7%
11.3%
$497M
$442M
$467M
Sep '23
$703M
$47M
23.0%
8.4%
$21M
—
$47M
Jun '23
$628M
$35M
23.1%
6.7%
-$24M
—
$35M
Mar '23
$569M
$12M
23.0%
4.4%
-$349M
—
$174M
Dec '22
$820M
$65M
22.4%
10.6%
$249M
$406M
$306M
Sep '22
$634M
$279M
20.5%
59.3%
-$17M
—
$63M
Jun '22
$627M
$25M
20.3%
6.7%
$4M
—
$69M
Mar '22
$612M
$36M
21.9%
9.2%
-$268M
—
$113M
Dec '21
$820M
$58M
18.7%
9.9%
$271M
$408M
$240M
Sep '21
$720M
$35M
18.2%
7.4%
$61M
—
$78M
Jun '21
$658M
$32M
19.3%
7.8%
$48M
—
$91M
Valuation over time
How the market has priced DRS against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 8.5× (Mar '23) to 42.6× (Jun '26).
The price-to-sales ratio has risen from 1.3× (Mar '23) to 3.2× (Jun '26).
The dividend yield has fallen from 11.4% (Mar '23) to 7.4% (Dec '23).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is DRS growing its revenue and profit?
Over the past 5 years, Leonardo Drs, Inc.'s revenue has grown 5.6% per year, and net income grown 26.7% per year. These are computed facts, not advice.
How much debt does DRS have?
As of FY2025, Leonardo Drs, Inc. reported $353M of total debt against $647M of cash.
What is DRS's profit margin?
In FY2025, gross margin was 23.8%, operating margin 9.5%, and net margin 7.6%.
What is DRS's P/E ratio?
As of Jun '26, Leonardo Drs, Inc. traded at a price-to-earnings ratio of about 42.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.